WallStSmart

The Clorox Company (CLX)vsUnilever PLC ADR (UL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Unilever PLC ADR generates 647% more annual revenue ($50.50B vs $6.76B). UL leads profitability with a 18.8% profit margin vs 11.2%. CLX appears more attractively valued with a PEG of 2.20. CLX earns a higher WallStSmart Score of 57/100 (C).

CLX

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.07

UL

Hold

46

out of 100

Grade: D+

Growth: 2.0Profit: 8.5Value: 4.3Quality: 5.0
Piotroski: 4/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$102.51

Current Price

$94.14

$8.37 premium

UndervaluedFair: $102.51Overvalued

Intrinsic value data unavailable for UL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX3 strengths · Avg: 9.3/10
Return on EquityProfitability
54.6%10/10

Every $100 of equity generates 55 in profit

Debt/EquityHealth
-66.9610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.7x8/10

Attractively priced relative to earnings

UL4 strengths · Avg: 8.8/10
Return on EquityProfitability
76.2%10/10

Every $100 of equity generates 76 in profit

Market CapQuality
$127.59B9/10

Large-cap with strong market position

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

Free Cash FlowQuality
$5.48B8/10

Generating 5.5B in free cash flow

Areas to Watch

CLX4 concerns · Avg: 3.5/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Free Cash FlowQuality
$-165.00M2/10

Negative free cash flow — burning cash

UL4 concerns · Avg: 2.3/10
Debt/EquityHealth
1.913/10

Elevated debt levels

PEG RatioValuation
10.832/10

Expensive relative to growth rate

Revenue GrowthGrowth
-3.2%2/10

Revenue declined 3.2%

EPS GrowthGrowth
-3.4%2/10

Earnings declined 3.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, Debt/Equity, P/E Ratio.

Bull Case : UL

The strongest argument for UL centers on Return on Equity, Market Cap, Operating Margin. Profitability is solid with margins at 18.8% and operating margin at 20.1%.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : UL

The primary concerns for UL are Debt/Equity, PEG Ratio, Revenue Growth. Debt-to-equity of 1.91 is elevated, increasing financial risk.

Key Dynamics to Monitor

CLX profiles as a value stock while UL is a declining play — different risk/reward profiles.

CLX carries more volatility with a beta of 0.55 — expect wider price swings.

CLX is growing revenue faster at 0.1% — sustainability is the question.

UL generates stronger free cash flow (5.5B), providing more financial flexibility.

Bottom Line

CLX scores higher overall (57/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Unilever PLC ADR

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Unilever PLC is a fast moving consumer goods company in Asia, Africa, the Middle East, Turkey, Russia, Ukraine, Belarus, America and Europe. The company is headquartered in London, the United Kingdom.

Want to dig deeper into these stocks?